NP Medical News about recurrent stroke; aspirin; extended-release dipyridamole; clopidogrel

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke
Evidence-Based Medicine, 06/10/09

Sacco RL - Rates of recurrent stroke were similar in the aspirin + ERDP and clopidogrel groups, although the criterion for non-inferiority was not met. Groups did not differ for the composite end point (13% in each group) or net risk of recurrent stroke or major bleeding event. Risk of intracranial haemorrhage was increased in the aspirin + ERDP group. In patients with ischaemic stroke, aspirin plus extended-release dipyridamole and clopidogrel resulted in similar rates of recurrent stroke.

<< Previous
6-month treatment with a low-glycaemic diet was better than a...

Next >>
Telemedicine in the management of chronic pain: a cost analysis...